Cost of CLL Management Expected to Skyrocket

By 2025 there will be an increasing number of people living with CLL due to improved survival conferred by emerging targeted therapies; however, the annual cost of CLL management for both patients and providers may impose a significant financial burden.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Tags: Hematologic Malignancies Leukemia & Lymphoma News Source Type: news